1. Comparison of 3D culture methods on human HepG2 cells. (16th September 2016) Authors: Lampen, A.; Luckert, C.; Schulz, C.; Lehmann, N.; Thomas, M.; Hofmann, U.; Hammad, S.; Hengstler, J.; Braeuning, A.; Hessel, S. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. (16th October 2015) Authors: Luckert, C.; Lenze, D.; Braeuning, A.; Lampen, A.; Hessel, S. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hepatotoxic pyrrolizidine alkaloids: Structure-dependent activation of PXR and PXR-mediated induction of CYP3A4 expression. (16th September 2016) Authors: Luckert, C.; Braeuning, A.; Hessel, S.; Lampen, A. Journal: Toxicology letters Issue: Volume 258(2016)Supplement Page Start: S256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hepatotoxicity of pyrrolizidine alkaloids in human hepatocytes and endothelial cells. (10th October 2018) Authors: Glück, J.; Ebmeyer, J.; Waizenegger, J.; Luckert, C.; Braeuning, A.; Lampen, A.; Hessel-Pras, S. Journal: Toxicology letters Issue: Volume 295(2018)Supplement 1 Page Start: S142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In vitro analysis of liver steatosis using adverse outcome pathways: A case study with cyproconazole. (10th October 2018) Authors: Luckert, C.; Braeuning, A.; de Sousa, G.; Durinck, S.; Katsanou, E.S.; Konstantinidou, P.; Machera, K.; Milani, E.S.; Peijnenburg, A.; Rahmani, R.; Rajkovic, A.; Spyropoulou, A.; Stamou, M.; Stoopen, G.; Sturla, S.J.; Zucchini-Pascal, N.; Lampen, A. Journal: Toxicology letters Issue: Volume 295(2018)Supplement 1 Page Start: S64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Induction of signaling pathways by different doses of flavonoid quercetin in human primary hepatocytes. (16th October 2015) Authors: Waizenegger, J.; Lenze, D.; Luckert, C.; Braeuning, A.; Seidel, A.; Lampen, A.; Hessel, S. Journal: Toxicology letters Issue: Volume 238(2015)Supplement Page Start: S258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P12-28 Test methods for metabolic effects of endocrine disrupting chemicals. (1st September 2022) Authors: Fritsche, K.; Lichtenstein, D.; Luckert, C.; Lasch, A.; Braeuning, A. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗